This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Purdue Pharma L.p.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Alessandra Cipriano
Introduction
Alessandra Cipriano is an accomplished inventor based in Eastchester, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in pain management. Her innovative approach combines the use of opioids with buprenorphine to enhance treatment efficacy while minimizing adverse effects.
Latest Patents
Cipriano holds a patent for a method of treatment and dosage forms thereof. The invention provides an oral dosage form that includes an amount of oxycodone and an amount of buprenorphine. The weight ratio of buprenorphine to oxycodone is greater than 1:40, calculated with the amount of buprenorphine expressed as the equimolar amount of buprenorphine base and the amount of oxycodone expressed as the equimolar amount of oxycodone hydrochloride. This innovative combination aims to reduce adverse pharmacodynamic responses, such as respiratory depression, compared to traditional opioid therapies.
Career Highlights
Cipriano is associated with Purdue Pharma L.P., where she continues to develop groundbreaking solutions in pain management. Her work is pivotal in addressing the challenges associated with opioid use, particularly in enhancing patient safety and treatment outcomes.
Collaborations
Cipriano collaborates with notable colleagues, including Salvatore Colucci and Stephen C. Harris. Their combined expertise contributes to the advancement of innovative treatments in the pharmaceutical industry.
Conclusion
Alessandra Cipriano's contributions to the field of pharmaceuticals exemplify the importance of innovation in improving patient care. Her patented methods represent a significant step forward in pain management, showcasing her dedication to enhancing treatment efficacy and safety.